Home LiteratureArticle Details
PMID: 29802200 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

The Journal of biological chemistry ·Vol. 293 ·No. 28 ·2018-00-13 ·Pages 11047-11066

Bishof I, Dammer EB, Duong DM, Kundinger SR, Gearing M, Lah JJ, Levey AI, Seyfried NT

Abstract

The U1 small nuclear ribonucleoprotein 70 kDa (U1-70K) and other RNA-binding proteins (RBPs) are mislocalized to cytoplasmic neurofibrillary Tau aggregates in Alzheimer's disease (AD), yet the co-aggregation mechanisms are incompletely understood. U1-70K harbors two disordered low-complexity domains (LC1 and LC2) that are necessary for aggregation in AD brain extracts. The LC1 domain contains highly repetitive basic (Arg/Lys) and acidic (Asp/Glu) residues, referred to as a basic-acidic dipeptide (BAD) domain. We report here that this domain shares many of the properties of the Gln/Asn-rich LC domains in RBPs that also aggregate in neurodegenerative disease. These properties included self-assembly into oligomers and localization to nuclear granules. Co-immunoprecipitations of recombinant U1-70K and deletions lacking the LC domain(s) followed by quantitative proteomic analyses were used to resolve functional classes of U1-70K-interacting proteins that depend on the BAD domain for their interaction. Within this interaction network, we identified a class of RBPs with BAD domains nearly identical to that found in U1-70K. Two members of this class, LUC7L3 and RBM25, required their respective BAD domains for reciprocal interactions with U1-70K and nuclear granule localization. Strikingly, a significant proportion of RBPs with BAD domains had elevated insolubility in the AD brain proteome. Furthermore, we show that the BAD domain of U1-70K can interact with Tau from AD brains but not from other tauopathies. These findings highlight a mechanistic role for BAD domains in stabilizing RBP interactions and in potentially mediating co-aggregation with the pathological AD-specific Tau isoforms.

Keywords
RNA processing RNA-binding protein Tau protein (Tau) intrinsically disordered protein mass spectrometry (MS) neurodegeneration protein aggregation protein–protein interaction proteomics systems biology
MeSH Terms
Alzheimer Disease/metabolism,pathology Amino Acid Sequence Brain/metabolism,pathology Dipeptides/chemistry,metabolism HEK293 Cells Humans Protein Interaction Domains and Motifs Protein Multimerization RNA-Binding Proteins/chemistry,metabolism Ribonucleoprotein, U1 Small Nuclear/chemistry,metabolism tau Proteins/chemistry,metabolism
Chemicals
Dipeptides MAPT protein, human RNA-Binding Proteins Ribonucleoprotein, U1 Small Nuclear tau Proteins
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Bishof Isaac
From the Departments of Biochemistry. | the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322.
Dammer Eric B
From the Departments of Biochemistry. | the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322.
Duong Duc M
From the Departments of Biochemistry. | the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322.
Kundinger Sean R
From the Departments of Biochemistry. | the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322.
Gearing Marla
the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322. | Pathology and Laboratory Medicine and.
Lah James J
the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322. | Neurology, and.
Levey Allan I
the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322. | Neurology, and.
Seyfried Nicholas T
From the Departments of Biochemistry, nseyfri@emory.edu. | the Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, Georgia 30322. | Neurology, and.
References (77)
77 references, click to expand
  1. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.
    EMBO J. 2012 Mar 7;31(5):1241-52 PMID: 22193716
  2. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
    Cell Syst. 2017 Jan 25;4(1):60-72.e4 PMID: 27989508
  3. Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.
    J Neuropathol Exp Neurol. 2018 Jan 1;77(1):40-49 PMID: 29145658
  4. The 7SK snRNP associates with the little elongation complex to promote snRNA gene expression.
    EMBO J. 2017 Apr 3;36(7):934-948 PMID: 28254838
  5. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
    Acta Neuropathol. 1991;81(6):591-6 PMID: 1831952
  6. The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD.
    Front Mol Neurosci. 2017 Feb 13;10:35 PMID: 28243191
  7. Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5' splice site recognition.
    Elife. 2015 Jan 02;4:null PMID: 25555158
  8. ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor.
    J Neurosci. 2014 Mar 19;34(12):4167-74 PMID: 24647938
  9. Phase transitions in the assembly of multivalent signalling proteins.
    Nature. 2012 Mar 07;483(7389):336-40 PMID: 22398450
  10. The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies.
    Nat Commun. 2012 Apr 03;3:766 PMID: 22473010
  11. Domain distribution and intrinsic disorder in hubs in the human protein-protein interaction network.
    Protein Sci. 2010 Aug;19(8):1461-8 PMID: 20509167
  12. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.
    Mol Cell Proteomics. 2014 Sep;13(9):2513-26 PMID: 24942700
  13. Polar zippers: their role in human disease.
    Protein Sci. 1994 Oct;3(10):1629-37 PMID: 7849580
  14. The EMBL-EBI bioinformatics web and programmatic tools framework.
    Nucleic Acids Res. 2015 Jul 1;43(W1):W580-4 PMID: 25845596
  15. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells.
    Immunity. 2010 Feb 26;32(2):279-89 PMID: 20171123
  16. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.
    Science. 2008 Mar 21;319(5870):1668-72 PMID: 18309045
  17. Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo.
    Nat Neurosci. 2018 Jan;21(1):72-80 PMID: 29273772
  18. RNA-binding proteins with prion-like domains in health and disease.
    Biochem J. 2017 Apr 7;474(8):1417-1438 PMID: 28389532
  19. Identification of a self-association domain in the Ewing's sarcoma protein: a novel function for arginine-glycine-glycine rich motifs?
    J Biochem. 2010 Jun;147(6):885-93 PMID: 20211855
  20. A new subtype of frontotemporal lobar degeneration with FUS pathology.
    Brain. 2009 Nov;132(Pt 11):2922-31 PMID: 19674978
  21. Probing mechanisms that underlie human neurodegenerative diseases in Drosophila.
    Annu Rev Genet. 2012;46:371-96 PMID: 22974305
  22. Multivalent Molecules as Modulators of RNA Granule Size and Composition.
    Biophys J. 2017 Jul 25;113(2):235-245 PMID: 28242011
  23. Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity.
    Cell Rep. 2016 May 17;15(7):1455-1466 PMID: 27160897
  24. Neuropathological stageing of Alzheimer-related changes.
    Acta Neuropathol. 1991;82(4):239-59 PMID: 1759558
  25. Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease.
    Brain Pathol. 2014 Jul;24(4):344-51 PMID: 24571648
  26. LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity.
    Sci Rep. 2016 Nov 18;6:36741 PMID: 27857158
  27. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels.
    Cell. 2012 May 11;149(4):753-67 PMID: 22579281
  28. Evidence for a direct role of the disease modifier SCNM1 in splicing.
    Hum Mol Genet. 2007 Oct 15;16(20):2506-16 PMID: 17656373
  29. RNA binding proteins and the genesis of neurodegenerative diseases.
    Adv Exp Med Biol. 2015;822:11-5 PMID: 25416971
  30. Compositional Control of Phase-Separated Cellular Bodies.
    Cell. 2016 Jul 28;166(3):651-663 PMID: 27374333
  31. RNA mis-splicing in disease.
    Nat Rev Genet. 2016 Jan;17(1):19-32 PMID: 26593421
  32. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles.
    Mol Cell. 2015 Mar 5;57(5):936-947 PMID: 25747659
  33. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
    Science. 2009 Feb 27;323(5918):1208-1211 PMID: 19251628
  34. WGCNA: an R package for weighted correlation network analysis.
    BMC Bioinformatics. 2008 Dec 29;9:559 PMID: 19114008
  35. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains.
    Cell. 2013 Nov 21;155(5):1049-1060 PMID: 24267890
  36. Andromeda: a peptide search engine integrated into the MaxQuant environment.
    J Proteome Res. 2011 Apr 1;10(4):1794-805 PMID: 21254760
  37. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R.
    Bioinformatics. 2008 Mar 1;24(5):719-20 PMID: 18024473
  38. Identification of functional U1 snRNA-pre-mRNA complexes committed to spliceosome assembly and splicing.
    Cell. 1989 Oct 20;59(2):349-58 PMID: 2529976
  39. RNA stores tau reversibly in complex coacervates.
    PLoS Biol. 2017 Jul 6;15(7):e2002183 PMID: 28683104
  40. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Neurology. 1991 Apr;41(4):479-86 PMID: 2011243
  41. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Proteomics. 2016 Dec;16(23):3042-3053 PMID: 27718298
  42. Alternative cleavage and polyadenylation: extent, regulation and function.
    Nat Rev Genet. 2013 Jul;14(7):496-506 PMID: 23774734
  43. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.
    Nat Biotechnol. 2008 Dec;26(12):1367-72 PMID: 19029910
  44. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.
    Mol Cell Biol. 2008 Oct;28(19):5924-36 PMID: 18663000
  45. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization.
    Cell. 2015 Sep 24;163(1):123-33 PMID: 26406374
  46. RNA granules.
    J Cell Biol. 2006 Mar 13;172(6):803-8 PMID: 16520386
  47. Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.
    J Biol Chem. 2014 Dec 19;289(51):35296-313 PMID: 25355317
  48. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16562-7 PMID: 24023061
  49. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Alzheimers Dement. 2018 Mar;14(3):352-366 PMID: 29107053
  50. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.
    Brain Res. 2012 Jun 26;1462:61-80 PMID: 22445064
  51. U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.
    Mol Neurodegener. 2014 Apr 28;9:15 PMID: 24773620
  52. Low-complexity regions within protein sequences have position-dependent roles.
    BMC Syst Biol. 2010 Apr 13;4:43 PMID: 20385029
  53. Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
    J Proteome Res. 2012 May 4;11(5):2721-38 PMID: 22416763
  54. Normalization and missing value imputation for label-free LC-MS analysis.
    BMC Bioinformatics. 2012;13 Suppl 16:S5 PMID: 23176322
  55. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.
    Am J Pathol. 1994 Dec;145(6):1496-508 PMID: 7992852
  56. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    EMBO Mol Med. 2018 Jan;10(1):48-62 PMID: 29191947
  57. The splicing factor U1-70K interacts with the SMN complex and is required for nuclear gem integrity.
    J Cell Sci. 2014 Sep 15;127(Pt 18):3909-15 PMID: 25052091
  58. Tau protein liquid-liquid phase separation can initiate tau aggregation.
    EMBO J. 2018 Apr 3;37(7):null PMID: 29472250
  59. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau.
    Nat Commun. 2017 Aug 17;8(1):275 PMID: 28819146
  60. Local Nucleation of Microtubule Bundles through Tubulin Concentration into a Condensed Tau Phase.
    Cell Rep. 2017 Sep 5;20(10):2304-2312 PMID: 28877466
  61. Alzheimer disease susceptibility loci: evidence for a protein network under natural selection.
    Am J Hum Genet. 2012 Apr 6;90(4):720-6 PMID: 22482808
  62. Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination.
    PLoS One. 2012;7(6):e38658 PMID: 22761693
  63. Blue native PAGE.
    Nat Protoc. 2006;1(1):418-28 PMID: 17406264
  64. Preparation of splicing competent nuclear extracts.
    Methods Mol Biol. 2014;1126:117-21 PMID: 24549659
  65. The U1 small nuclear ribonucleoprotein (snRNP) 70K protein is transported independently of U1 snRNP particles via a nuclear localization signal in the RNA-binding domain.
    Mol Cell Biol. 1994 Jul;14(7):4662-70 PMID: 7516470
  66. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.
    Hum Mol Genet. 2013 Jul 1;22(13):2676-88 PMID: 23474818
  67. Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies.
    J Neurosci. 2012 Jun 13;32(24):8270-83 PMID: 22699908
  68. GO-Elite: a flexible solution for pathway and ontology over-representation.
    Bioinformatics. 2012 Aug 15;28(16):2209-10 PMID: 22743224
  69. Dysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders.
    Front Mol Neurosci. 2017 Apr 04;10:89 PMID: 28420962
  70. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
    Acta Neuropathol. 2007 Jul;114(1):63-70 PMID: 17492294
  71. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
    Nat Genet. 2000 May;25(1):25-9 PMID: 10802651
  72. Cryo-EM structures of tau filaments from Alzheimer's disease.
    Nature. 2017 Jul 13;547(7662):185-190 PMID: 28678775
  73. Overexpression of the arginine-rich carboxy-terminal region of U1 snRNP 70K inhibits both splicing and nucleocytoplasmic transport of mRNA.
    Genes Dev. 1995 Jun 1;9(11):1400-10 PMID: 7797079
  74. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
    Nature. 2013 Mar 28;495(7442):467-73 PMID: 23455423
  75. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles.
    Cell. 2016 Oct 20;167(3):774-788.e17 PMID: 27768896
  76. Altered ribostasis: RNA-protein granules in degenerative disorders.
    Cell. 2013 Aug 15;154(4):727-36 PMID: 23953108
  77. The Cajal body.
    Biochim Biophys Acta. 2008 Nov;1783(11):2108-15 PMID: 18755223
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
1083-351X
Published
2018-00-13
Epub
2018-00-25
Pages
11047-11066
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC6052236
Subset
IM
Grants
NIA NIH HHS · R01 AG053960 · United States
NIA NIH HHS · P50 AG025688 · United States
NIA NIH HHS · R21 AG054206 · United States
NIA NIH HHS · U01 AG046161 · United States
NINDS NIH HHS · P30 NS055077 · United States
NINDS NIH HHS · T32 NS007480 · United States
NINDS NIH HHS · F31 NS093859 · United States
NIGMS NIH HHS · T32 GM008367 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com